Asymmetric large-for-gestational-age infants of type 1 diabetic women: morbidity and abdominal growth

Am J Perinatol. 2010 Sep;27(8):603-10. doi: 10.1055/s-0030-1249362. Epub 2010 Mar 11.

Abstract

We sought to examine neonatal morbidity in four groups of offspring (asymmetric large for gestational age [LGA], symmetric LGA, asymmetric non-LGA, symmetric non-LGA) exposed in utero to maternal type 1 diabetes, and the association between rate of fetal abdominal circumference growth and asymmetric LGA. We performed a secondary analysis of 302 singleton pregnancies. Neonatal morbidity (respiratory distress syndrome, polycythemia, hypoglycemia, hyperbilirubinemia, acidosis, and composite morbidity [any of the five]) was assessed. Serial ultrasound examinations after 20 weeks' gestation were available for 35 fetuses. Logistic regression and general linear mixed modeling were used for analysis. Asymmetric LGA infants had 3.5-, 2.2-, and 3.2-fold greater odds of hypoglycemia, hyperbilirubinemia, and composite morbidity, respectively, compared with symmetric non-LGA infants. The rate of growth of the abdominal circumference in asymmetric LGA infants (1.11 cm/wk) was greater than for both the symmetric LGA infants (0.87 cm/wk, P = 0.09) and the symmetric non-LGA infants (0.87 cm/wk, P = 0.03). Asymmetric LGA infants are at higher risk for morbidity than symmetric LGA and non-LGA infants. Intrauterine growth rate of the abdominal circumference may potentially be used as a marker to identify the asymmetric LGA and thereby aid in the identification of newborns at greatest risk for perinatal complications.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Birth Weight* / physiology
  • Congenital Abnormalities* / diagnosis
  • Congenital Abnormalities* / genetics
  • Congenital Abnormalities* / mortality
  • Congenital Abnormalities* / physiopathology
  • Congenital Abnormalities* / prevention & control
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diabetes Mellitus, Type 1 / therapy
  • Female
  • Humans
  • Infant, Newborn
  • Perinatal Care
  • Perinatal Mortality
  • Pregnancy
  • Pregnancy Outcome / epidemiology
  • Pregnancy in Diabetics / epidemiology
  • Pregnancy in Diabetics / genetics*
  • Pregnancy in Diabetics / physiopathology
  • Pregnancy in Diabetics / therapy
  • Prenatal Care
  • Risk Factors
  • Ultrasonography, Prenatal